Skip to main content
. 2015 Aug 27;10(8):e0134974. doi: 10.1371/journal.pone.0134974

Fig 3.

Fig 3

(A) Serum DKK-1 level among axial SpA patients and controls at baseline. Each point represents 1 patient. Data are mean ± SD. *** p< 0.0001. (B) Distribution of DKK-1 levels in controls and axial SpA patients.